Registering a CAGR of 6.1% over the forecast period, the market value of Cell-Free Protein Expression System is expected to reach US$ 409.80 million in the year 2027.
Cell-free protein expression or in vitro protein synthesis is a process that involves the production of the recombinant proteins in cell lysate solution, without using cell culture or living cells. Cell-free protein expression can be carried out using different cell lysates, such as those of E. coli, rabbit reticulocytes, wheat germs, human cells, and insect cells.
The significant factors for the growth of the cell-free protein expression market include the increasing R&D in proteomics and genomics, high prevalence of cancer and infectious diseases, and shorter-expression time and structural modification. Cell-free protein expression employs cell lysates to produce the desired recombinant proteins. The primary advantage of this technique is the aversion of workflow hurdles of maintaining cell culture or living cells. Cell lysates are produced by the breakdown and use of cellular components of eukaryotic or bacterial cells. Several cell-free protein expression systems are currently commercially available, based on E. coli, rabbit reticulocytes, wheat germs, human cell lines, and insect cells.
The report aspects discussed the profile of the top manufacturers of the global Cell-Free Protein Expression System market. These aspects include financial status of major companies, trending advancements and entire market scenario. Growth of the report have examined Cell-Free Protein Expression System Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.
Thermo Fisher Scientific Completes Acquisition of PeproTech, a Leader in Recombinant Proteins
January 5, 2022 – Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and PeproTech, Inc., a leading developer and manufacturer of recombinant proteins, today announced that Thermo Fisher completed its acquisition of PeproTech on December 30, 2021 for a total cash purchase price of approximately $1.85 billion. Based in Cranbury, New Jersey, PeproTech is a privately held provider of bioscience reagents known as recombinant proteins, including cytokines and growth factors. Recombinant proteins are used in the development and manufacturing of cell and gene therapies as well as in broader cell culture applications, especially for use in cellular research models. PeproTech's recombinant proteins portfolio complements Thermo Fisher's cell culture media products and will enable Thermo Fisher to provide customers significant benefits through an integrated offering.
Merck Completes Acquisition of Exelead and Plans to Invest More Than € 500 Million in Technology Scale-Up
23 FEB 2022 – Merck, a leading science and technology company, today announced the closing of the transaction to acquire Exelead, following regulatory clearances and the fulfillment of other customary closing conditions, for approximately USD 780 million in cash. The business combination is expected to enable Merck’s Life Science business sector to provide its customers with comprehensive end-to-end contract development and manufacturing organization (CDMO) services across the mRNA value chain. Merck plans to further invest over € 500 million to scale up Exelead’s technology over the next ten years.
Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
By Application, it is segmented into
North America is found to hold a major share in the cell-free protein expression market, and it is expected to show a similar trend over the forecast period, without significant fluctuations. The primary factors behind the large market size include the increasing prevalence of chronic diseases, such as cancer, aging population, growing demand for targeted and personalized medicine, the presence of major R&D facilities, and favorable government initiatives in the United States. There is a growing trend of cell-based research in the US academia and biotechnology industries. In recent years, several government initiatives have been supplementing the growth of the cell-free protein expression market in the United States.
In the North American region, the United States holds the largest market share due to factors such as the increasing burden of cancer cases in the country, which is anticipated to stimulate the demand for cell-free protein expression market.
The Cell-Free Protein Expression System Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Cell-Free Protein Expression System Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Scope of the Report covers Cell-Free Protein Expression System Market with detailed analysis of the overall scenario for the market. It also highlights the business participants environment in the global marketplace. This report also provides an overview of leading companies covering the latest successful marketing strategies, market contributions, current and historical background and latest market happenings to help key organizations to grow and generate larger profits. Business players will greatly benefit from this Cell-Free Protein Expression System Market analysis report as it has vital details to provide about regional markets, expected opportunities for the prediction time period 2022-2027. Growth between segments is used to understand the different growth factors that are expected to dominate the market as a whole and to develop strategies to differentiate between key applications and target markets. It further reveals how worldwide market is working through efficient information graphics.
Reports Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 6.1% during the review period (2022 to 2027). |
By Type |
|
By Application |
|
By Companies | Thermo Fisher Scientific Inc. (NYSE :TMO), Promega, Takara Bio Inc. (Tokyo :4974.T), New England Biolabs, Creative Biolabs, CellFree Sciences, Synthelis, Arbor Bioscience, |
Regions Covered | • North America • Europe • Asia-Pacific • Rest of the World |
Countries Covered | • US • Canada • Germany • France • UK • Italy • Spain • Rest of Europe • China • Japan • India • Australia • South Korea • Rest of Asia-Pacific • Middle East & Africa • Latin America |
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 106 |
Customization Available | Yes, the report can be customized as per your needs |
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
Frequently Asked Questions
What is the study period of this market?
The Cell-Free Protein Expression System Market is studied from 2017 - 2027.
Who are the key players in Cell-Free Protein Expression System Market?
Thermo Fisher Scientific Inc. (NYSE :TMO), Promega, Takara Bio Inc. (Tokyo :4974.T), New England Biolabs, Creative Biolabs, CellFree Sciences, Synthelis, Arbor Bioscience, Cube Biotech, Cambridge Isotope Laboratories, Profacgen, Bioneer, GeneCopoeia and others.
What are the significant types of Cell-Free Protein Expression System Market?
E.Coli System, Rabbit Reticulocytes System, Wheat Germ System, Insect Cells System, Mammalian System, Others.
What are the major end-use applications of Cell-Free Protein Expression System Market?
Pharmaceutical, Academic Research, Others.
What segments are covered in the Cell-Free Protein Expression System Market report?
The Global Cell-Free Protein Expression System Market is segmented on the basis of Product, Application, and Geography.
How can I get a sample report/company profile for the Cell-Free Protein Expression System Market?
The sample report for the Cell-Free Protein Expression System Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.